Roshini Markandu

CYP-Mediated Sulfoximine Deimination of AZD6738

G. Scarfe, B. Jones, Chungang Gu, 2017, Drug Metabolism and Disposition.

Impact of Interindividual Differences in Plasma Fraction Unbound on the Pharmacokinetics of a Novel Syk Kinase Inhibitor in Beagle Dogs

B. Jones, A. Pike, Roshini Markandu, 2021, Drug Metabolism and Disposition.

Drug Metabolite Identification using UHPLC UV Spectroscopy and Parallelized Scans on a Tribrid Orbitrap Mass Spectrometer.

Roshini Markandu, Scott Martin, A. Orton, 2020, Rapid communications in mass spectrometry : RCM.

Using in vitro methods to determine P450s responsible for metabolism and discrimination from other oxidative pathways

V. Reddy, B. Jones, T. E. Bapiro, 2020 .

Abstract 1042: Preclinical pharmacokinetic and metabolic characterization of the next generation oral SERD AZD9833

James S. Scott, T. Klinowska, D. Mcginnity, 2020 .

Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo Efficacy.

E. Hennessy, Nichola L. Davies, A. Doherty, 2021, Journal of medicinal chemistry.

Development of a Quantification Method for Arginase Inhibitors by LC-MS/MS with Benzoyl Chloride Derivatization

Petar Pop-Damkov, Roshini Markandu, Raymond M. Finlay, 2024, Journal of Pharmaceutical and Biomedical Analysis.

CYP-Mediated Sulfoximine Deimination of AZD6738

G. Scarfe, B. Jones, Chungang Gu, 2017, Drug Metabolism and Disposition.